Repro Historical Cash Flow
| KRMD Stock | USD 3.98 0.06 1.49% |
Analysis of Repro Med cash flow over time is an excellent tool to project Repro Med Systems future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 18.3 M or Depreciation of 913.9 K as it is a great indicator of Repro Med ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Repro Med Systems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Repro Med Systems is a good buy for the upcoming year.
Repro |
About Repro Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Repro balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Repro's non-liquid assets can be easily converted into cash.
Repro Med Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Repro Med Systems to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Repro Med operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Repro Med's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Repro Med Systems current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, Repro Med's Change To Inventory is projected to increase significantly based on the last few years of reporting. The current year's Change In Working Capital is expected to grow to about 1.3 M, whereas Free Cash Flow is projected to grow to (5.4 M).
| 2023 | 2024 (projected) | Dividends Paid | 212.5K | 223.1K | Depreciation | 870.4K | 913.9K |
Repro Med cash flow statement Correlations
Click cells to compare fundamentals
Repro Med Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Repro Med cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (2.8K) | (3.5M) | 0.0 | 406.6K | 366.0K | 384.3K | |
| Change To Inventory | (284.6K) | (4.4M) | 723.4K | (298.5K) | 2.9M | 3.1M | |
| Change In Cash | 2.1M | 21.4M | (2.0M) | (7.9M) | (5.9M) | (5.6M) | |
| Free Cash Flow | (104.9K) | (1.8M) | (4.7M) | (8.2M) | (5.7M) | (5.4M) | |
| Change In Working Capital | (1.5M) | (2.9M) | (1.1M) | 1.4M | 1.2M | 1.3M | |
| Begin Period Cash Flow | 3.7M | 5.9M | 27.3M | 25.3M | 17.4M | 18.3M | |
| Other Cashflows From Financing Activities | 184.8K | (1.0M) | (366.2K) | 406.6K | (33.5K) | (35.1K) | |
| Depreciation | 340.2K | 418.6K | 463.1K | 587.1K | 870.4K | 913.9K | |
| Capital Expenditures | 425.5K | 1.1M | 375.2K | 2.8M | 814.6K | 433.9K | |
| Total Cash From Operating Activities | 320.6K | (743.3K) | (4.3M) | (5.4M) | (4.9M) | (4.6M) | |
| Change To Account Receivables | (1.8M) | 669.7K | (1.0M) | 34.0K | 457.2K | 480.0K | |
| Net Income | 564.3K | (1.2M) | (4.6M) | (8.7M) | (13.7M) | (13.1M) | |
| Total Cash From Financing Activities | 501.3K | 23.2M | 2.7M | 279.5K | (218.9K) | (207.9K) | |
| End Period Cash Flow | 5.9M | 27.3M | 25.3M | 17.4M | 11.5M | 12.1M | |
| Other Non Cash Items | (56.4K) | 1.3M | (1.0K) | 212.5K | 6.0M | 6.3M | |
| Stock Based Compensation | 1.2M | 1.6M | 2.7M | 3.1M | 2.8M | 2.9M | |
| Investments | 1.3M | (1.0M) | (366.2K) | (2.8M) | (814.6K) | (855.3K) | |
| Total Cashflows From Investing Activities | 1.3M | (1.0M) | (366.2K) | (2.8M) | (2.5M) | (2.4M) | |
| Change To Operating Activities | 235.7K | 990.1K | (1.5M) | 504.0K | 453.6K | 476.3K | |
| Other Cashflows From Investing Activities | 1.7M | (115.5K) | (366.2K) | (40.5K) | (46.6K) | (48.9K) | |
| Change To Netincome | 961.6K | 3.0M | 890.6K | 1.1M | 1.2M | 882.4K | |
| Change To Liabilities | 119.2K | 52.3K | 692.6K | 1.9M | 2.2M | 2.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.26) | Revenue Per Share 0.674 | Quarterly Revenue Growth 0.215 | Return On Assets (0.14) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.